The Director, Product Management will develop, manage and execute a compelling marketing strategy that aligns with organizational objectives to meet/exceed business revenue/margin goals through strong leadership and comprehension of the true needs and expectations of the customer.
The Director, Product Management is responsible for MaxCyte’s product development and global strategy for the technology products, consumables, parts and services. This position provides commercial leadership to develop and coordinate a global product and commercial strategy that includes existing product enhancements, new product roadmap, product development and new product introductions.
The position is responsible for the global pricing strategy, research expansion and positioning, monitoring quality, complaints and customer satisfaction, and developing strategies to constantly improve market awareness, share and profitability.
The Director, Product Management will develop a deep understanding of customer expectations with product functionality, evaluate and respond to market conditions across all regions (Asia Pacific, EMEA, and the Americas). He/she will create and nurture brand awareness and perception among researchers and ensure compliance with current regulations, standards and policies. In addition, the Director, Product Management is accountable for developing and creating new innovative products and services that will build MaxCyte’s brand leading to achievement of global revenue, margin and market share objectives.
Job Responsibilities:
Requirements
MaxCyte offers a base salary, annual bonus, and equity. MaxCyte also offers a comprehensive benefits package including health, dental, vision, life, and disability insurance and generous time off.
MaxCyte is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, sex, sexual orientation, gender identity, religion, national origin, disability, veteran status, age, marital status, pregnancy, genetic information, or other legally protected status

We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health.